Concepedia

Torjan Haslerud

TH

Statistics

Publications

14

Citations

785

H-Index

12

Active since

2011

Affiliations

University Hospital Bonn(Current)

Haukeland University Hospital

University of Bergen

Oslo University Hospital

Charité - Universitätsmedizin Berlin

Torjan Haslerud is an author at University Hospital Bonn specializing in medicine, radiology, and oncology.

Top concepts

Publications per year

2011–2023

14

Publications

14

Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours

Samer Ezziddin, Feras Khalaf, Maria Vanezi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 185 citations

, , +9

Specific efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced neuroendocrine tumours of the small intestine

Amir Sabet, Kristina Dautzenberg, Torjan Haslerud et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 102 citations

, , +9

Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumours

Amir Sabet, Torjan Haslerud, Ulrich‐Frank Pape et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 96 citations

, , +4

Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with 177Lu-octreotate

Amir Sabet, Khaled Ezziddin, Ulrich‐Frank Pape et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 89 citations

, , +7

<sup>90</sup>Y Radioembolization After Radiation Exposure from Peptide Receptor Radionuclide Therapy

Samer Ezziddin, Carsten Meyer, Stanislawa Kahancova et al. · Journal of Nuclear Medicine · 2012 · 73 citations · Full text

1–5 of 14